Troels Yndigegn
1 – 10 of 45
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Percutaneous and surgical management of aortic stenosis in the SWEDEHEART registry (2013–2023) : a nationwide observational study
- Contribution to journal › Article
- 2025
-
Mark
Deferral of left main coronary artery revascularization via IVUS or coronary physiology - Long-term outcomes from the SWEDEHEART registry
- Contribution to journal › Article
-
Mark
The prognostic value of global longitudinal strain in patients with myocardial infarction and preserved ejection fraction : a prespecified substudy of the REDUCE-AMI trial
- Contribution to journal › Article
-
Mark
An in-depth analysis of coronary computed tomography angiography segmental findings in acute spontaneous coronary artery dissection – a prospective multicenter study
- Contribution to journal › Article
-
Mark
Circulating soluble LOX-1 and patient prognosis after an acute coronary syndrome
(2025) In Heart
- Contribution to journal › Article
-
Mark
A Vessel-Specific Analysis of Deferred Lesions Using the Instantaneous Wave-Free Ratio and Fractional Flow Reserve
- Contribution to journal › Article
-
Mark
Long-Term Clinical Outcomes After IFR- vs FFR-Guided Coronary Revascularization : Insights From the SWEDEHEART National Registry
- Contribution to journal › Article
- 2024
-
Mark
Eligibility for lipid-lowering therapy when applying systemic coronary risk estimation 2 according to guidelines on apparently healthy middle-Aged individuals
- Contribution to journal › Article
-
Mark
Shedding of membrane complement inhibitors CD59 and CD46 into the circulation is associated with poor prognosis in acute coronary syndrome patients : a cohort study
- Contribution to journal › Article
-
Mark
Short- and long-term effects of beta-blockers on symptoms of anxiety and depression in patients with myocardial infarction and preserved left ventricular function : a pre-specified quality of life sub-study from the REDUCE-AMI trial
- Contribution to journal › Article
